Only one study was found in the literature where a limited number of PSP and FTD patients had been screened for NPC1 and NPC2 gene mutations, but no carriers were found in these patient groups (Papandreou and Gissen 2016). Here, NPC2 is linked to supranuclear palsy, progressive, 1.